Overview

Onsite Buprenorphine Treatment at Syringe Exchange Programs

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Montefiore Medical Center
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine